Carcinoembryonic Antigen in Gastric Tumors
Author Information
Author(s): M.S. Hockey, H.J. Stokes, H. Thompson, C.S. Woodhouse, F. Macdonald, J.W.L. Fielding, C.H.J. Ford
Primary Institution: Queen Elizabeth Hospital
Hypothesis
What is the expression and heterogeneity of carcinoembryonic antigen (CEA) in primary and metastatic gastric tumors?
Conclusion
The study found that CEA is expressed in the majority of gastric carcinomas, but there is significant heterogeneity in its expression within and between tumors.
Supporting Evidence
- 92% of primary tumors reacted positively with the CEA antibody.
- 83% of lymph node metastases were found to be CEA positive.
- 20% of patients had a mixture of positive and negative metastases.
Takeaway
This study looked at a special marker in stomach cancer and found that while most tumors show it, there are big differences in how much of it is present.
Methodology
The study used a monoclonal antibody and an immunoperoxidase technique to assess CEA expression in tumor samples from patients.
Limitations
The study may not be directly comparable to previous studies due to differences in methods and sample sizes.
Participant Demographics
Patients included 119 individuals with gastric tumors, with samples from both primary tumors and lymph node metastases.
Want to read the original?
Access the complete publication on the publisher's website